Nutritional and safety outcomes from an open-label micronutrient intervention for pediatric bipolar spectrum disorders
- PMID: 24138009
- PMCID: PMC3804335
- DOI: 10.1089/cap.2012.0098
Nutritional and safety outcomes from an open-label micronutrient intervention for pediatric bipolar spectrum disorders
Abstract
Objective: The purpose of this study was to report the safety, tolerability, and serum micronutrient concentrations and their correlations with mood changes from an 8 week pilot feasibility study of a 36 ingredient multinutrient supplement, EMPowerplus (EMP+), for pediatric bipolar spectrum disorders (BPSD).
Methods: Ten children ages 6-12 received EMP+ escalating from one to four capsules t.i.d., with four children increased to the maximum suggested dose, five capsules t.i.d. Outcome measures were micronutrient concentrations in serum and red blood cells, vital signs, body mass index (BMI), dietary intake (Food Frequency Questionnaire and 24 hour dietary recall interview), and mood and global functioning ratings.
Results: Seven children (70%) completed the study. Three (30%) terminated early for tolerability and compliance issues. Adverse effects were mild and transient, and chiefly consisted of initial insomnia or gastrointestinal (GI) upset. No differences occurred in BMI (p = 0.310) or waist-hip ratio (WHR; p = 0.674) pre- to postsupplementation. Four of the tested serum vitamin concentrations increased from pre- to postsupplementation: vitamin A-retinol, vitamin B6, vitamin E-α-tocopherol; and folate (all p<0.05). The increase in serum 25-OH vitamin D approached significance (p = 0.063). No differences were found in dietary intake pre- to postsupplementation, suggesting that blood nutrient level increases were caused by EMP+.
Conclusions: In this open prospective study, short-term use of EMP+ in children with BPSD appeared safe and well-tolerated, with a side effect profile preferable to first-line psychotropic drugs for pediatric bipolar spectrum disorders. A double-blind, randomized clinical trial is feasible, appears safe, and is warranted by open-label clinical outcomes and plausible mechanisms of action, combined with documentation of increased serum concentrations of specific micronutrients.
Similar articles
-
Feasibility of a nutritional supplement as treatment for pediatric bipolar spectrum disorders.J Altern Complement Med. 2012 Jul;18(7):678-85. doi: 10.1089/acm.2011.0270. Epub 2012 Jul 2. J Altern Complement Med. 2012. PMID: 22747095 Clinical Trial.
-
Multinutrient supplement as treatment: literature review and case report of a 12-year-old boy with bipolar disorder.J Child Adolesc Psychopharmacol. 2009 Aug;19(4):453-60. doi: 10.1089/cap.2008.0157. J Child Adolesc Psychopharmacol. 2009. PMID: 19702498 Review.
-
Clinically Significant Symptom Reduction in Children with Attention-Deficit/Hyperactivity Disorder Treated with Micronutrients: An Open-Label Reversal Design Study.J Child Adolesc Psychopharmacol. 2015 Dec;25(10):783-98. doi: 10.1089/cap.2015.0105. J Child Adolesc Psychopharmacol. 2015. PMID: 26682999 Free PMC article.
-
Can we predict treatment response in children with ADHD to a vitamin-mineral supplement? An investigation into pre-treatment nutrient serum levels, MTHFR status, clinical correlates and demographic variables.Prog Neuropsychopharmacol Biol Psychiatry. 2019 Mar 8;89:181-192. doi: 10.1016/j.pnpbp.2018.09.007. Epub 2018 Sep 12. Prog Neuropsychopharmacol Biol Psychiatry. 2019. PMID: 30217770 Clinical Trial.
-
[Antipsychotics in bipolar disorders].Encephale. 2004 Sep-Oct;30(5):417-24. doi: 10.1016/s0013-7006(04)95456-5. Encephale. 2004. PMID: 15627046 Review. French.
Cited by
-
Vitamin-mineral treatment improves aggression and emotional regulation in children with ADHD: a fully blinded, randomized, placebo-controlled trial.J Child Psychol Psychiatry. 2018 Mar;59(3):232-246. doi: 10.1111/jcpp.12817. Epub 2017 Oct 2. J Child Psychol Psychiatry. 2018. PMID: 28967099 Free PMC article. Clinical Trial.
-
Rationale and design of an international randomized placebo-controlled trial of a 36-ingredient micronutrient supplement for children with ADHD and irritable mood: The Micronutrients for ADHD in Youth (MADDY) study.Contemp Clin Trials Commun. 2019 Oct 26;16:100478. doi: 10.1016/j.conctc.2019.100478. eCollection 2019 Dec. Contemp Clin Trials Commun. 2019. PMID: 31763491 Free PMC article.
-
Future directions for research on youth with bipolar spectrum disorders.J Clin Child Adolesc Psychol. 2013;42(5):734-47. doi: 10.1080/15374416.2013.817312. Epub 2013 Aug 5. J Clin Child Adolesc Psychol. 2013. PMID: 23915232 Free PMC article.
-
Annual Research Review: Micronutrients and their role in the treatment of paediatric mental illness.J Child Psychol Psychiatry. 2025 Apr;66(4):477-497. doi: 10.1111/jcpp.14091. Epub 2024 Dec 20. J Child Psychol Psychiatry. 2025. PMID: 39703999 Review.
-
Micronutrients for Attention-Deficit/Hyperactivity Disorder in Youths: A Placebo-Controlled Randomized Clinical Trial.J Am Acad Child Adolesc Psychiatry. 2022 May;61(5):647-661. doi: 10.1016/j.jaac.2021.07.005. Epub 2021 Jul 22. J Am Acad Child Adolesc Psychiatry. 2022. PMID: 34303786 Free PMC article. Clinical Trial.
References
-
- Alpert JE. Fava M. Nutrition and depression: The role of folate. Nutr Rev. 1997;55:145. - PubMed
-
- Ambrosini PJ. Metz C. Prabucki K. Lee JC. Videotape reliability of the third revised edition of the K-SADS. J Am Acad Child Adolesc Psychiatry. 1989;28:723–728. - PubMed
-
- Text Revision. 4th ed. Washington, DC: American Psychiatric Association; 2000. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders.
-
- Axelson D. Birmaher BJ. Brent D. Wassick S. Hoover C. Bridge J. Ryan N. A preliminary study of the Kiddie Schedule for Affective Disorders and Schizophrenia for School-Age Children Mania Rating Scale for Children and Adolescents. J Child Adolesc Psychopharmacol. 2003;13:463–470. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical